|
| ephrin-B2 knockout mice display defects in angiogenesis by both arteries and veins in the capillary networks of the head and yolk sac as well as in myocardial trabeculation ( | |
loss of the ephrinB2 cytoplasmic domain in mouse results in midgestation lethality ( |
|
ephrinB2DeltaV mice expressing ephrinB2 lacking the C-terminal PDZ interaction site exhibited major lymphatic defects, including a failure to remodel their primary lymphatic capillary plexus into a hierarchical vessel network, hyperplasia, and lack of luminal valve formation ( |
|
ephrinB2(5F/5F) mice, expressing ephrinB2 in which the five conserved tyrosine residues were replaced by phenylalanine to disrupt phosphotyrosine-dependent signaling events, displayed only a mild lymphatic phenotype ( |
|
deletions of the gene reveal its essential roles for conduit vessel development in mice, suggesting similar functions during human vascular development and deregulation in vascular malformations ( |
|
Efnb2(-/-) knockout show neuronal migration defects that recapitulate the ones observed in the neocortex, hippocampus and cerebellum of the reeler mouse ( |
|
triple ephrin B1, B2, B3 knockouts knockout show neuronal migration defects that recapitulate the ones observed in the neocortex, hippocampus and cerebellum of the reeler mouse ( |